Speaker
Associate Director, Translational Medicine, Cabaletta Bio
Thomas Furmanak, Associate Director, Translational Medicine at Cabaletta Bio, is speaking at 4th Cell Therapy for Autoimmune Disease Summit 2026 (Philadelphia, United States of America, 1–3 Dec 2026) in the session “Evaluating No Preconditioning Approaches in Autoimmune Therapies”.
1–3 Dec 2026Philadelphia, United States of America
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Thomas Furmanak, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].